Eileen Jackson
11Patents
1h-index
16Co-inventors
40Inventor score
Filing activity: Oct 3, 2014 → Oct 2, 2017
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9556203B2 | Conformationally restricted P13K and mTOR inhibitors | Chemistry; Metallurgy | 7 | Active |
| US10179797B2 | Phosphinic peptide derivatives for use as MMP-12 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10561702B2 | Method for the treatment of skin disorders using dipeptide diaminobutyroyl benzylamide diacetate | Human Necessities | 0 | Active |
| US10570075B2 | Compounds | Chemistry; Metallurgy | 0 | Active |
| US10849838B2 | Biaromatic vitamin D analogs | Chemistry; Metallurgy | 0 | Active |
| US11168054B2 | Biaromatic compounds, which are vitamin D analogs | Human Necessities | 0 | Active |
| US10470991B2 | (R)-N-(adamantyl-2-yl)pyrrolidine-2-carboxamide derivatives for cosmetic use | Chemistry; Metallurgy | 0 | Active |
| US11591367B2 | Melanocortin-1-receptor agonists | Human Necessities | 0 | Active |
| US10550097B2 | Selective 11-beta-hydroxysteroid dehydrogenase type 1 inhibitors | Chemistry; Metallurgy | 0 | Active |
| US10336675B2 | Biaromatic vitamin D analogs | Chemistry; Metallurgy | 0 | Active |
| US10836791B2 | Compounds | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.